A Study to Assess the Effectiveness and Safety of a New Drug to Prevent Preterm Delivery in Pregnant Women at Increased-Risk for Preterm Delivery

Study Summary

The purpose of this research study is to evaluate the usefulness of vaginal gel versus placebo (a substance identical to material being tested that contains no medicine) in decreasing the pre-term birth rate in a population of pregnant women at high-risk for pre-term birth. This drug is still being tested for this use and is not approved for sale in the United States for pre-term birth by the FDA.

Participation Details

• Women 18 to 45 years old
• Women whose last pregnancy was a single premature birth (5 to 8.5 months)
• Must provide documentation of premature birth

Study Director: Eileen Wang, MD
Department: Obstetrics and Gynecology, Section of Maternal Fetal Medicine

For more information contact:
Barbara Harding-Clay
5841 S. Maryland Avenue, MC 2050
Chicago, IL 60637
(773) 834-3957
womenshealth@uchicago.edu

IRB: #14040B